ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2019
Strong sales growth during 2019; total revenue increased with a total of 47% for Q4 and 33% for the full year 2019, compared with the previous year.The revenue in December for Zinzino's sales markets increased by 84% to MSEK 66.6 (36.1) due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 56% and amounted to MSEK 2.8 (6.3) due to high level of internal production during the month. Overall the Group increased revenues by 64% to MSEK 69.3 (42.4) compared with the previous year. The fourth quarter of 2019 became the strongest sales quarter in history of